Bank of America
SKYE icon

Bank of America’s Skye Bioscience SKYE Stock Holding History

Bank of America’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-586
Closed -$438 – 7018
2025
Q4 		$438 Buy
586
+445
+316% +$650 ﹤0.01% 6580
2025
Q3 		$554 Sell
141
-660
-82% -$2.49K ﹤0.01% 7571
2025
Q2 		$3.35K Sell
801
-10,960
-93% -$22.7K ﹤0.01% 7356
2025
Q1 		$18.7K Sell
11,761
-27,496
-70% -$75.1K ﹤0.01% 6987
2024
Q4 		$111K Buy
39,257
+10,696
+37% +$44.7K ﹤0.01% 6348
2024
Q3 		$112K Buy
28,561
+16,991
+147% +$95.3K ﹤0.01% 6282
2024
Q2 		$92.7K Buy
+11,570
New +$137K ﹤0.01% 6283

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM